Tom O'Brien


Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.




Safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.


  1. PRP should be applied to the same patient from whom the blood was drawn.
  2. Storage of tubes containing blood at or below 0°C may result in tube breakage.
  3. Storage of tubes above 40°C may damage the gel stability.
  4. Do not remove conventional rubber stoppers by rolling with a thumb. Remove stoppers with a twist and pull motion.
  5. Do not use tubes if foreign matter is present.
  6. All liquid preservatives and anticoagulants are clear. Do not use tubes after their expiration date.
  7. Do not re-sterilize and do not attempt to clean this product.
  8. Do not use products if pouch is damaged.
  9. Use prepared platelet concentrate material within 4 hours after drawing blood from patient.


  1. Practice Universal Precautions. Process all procedures under controlled environment, use gloves, gowns, eye protection, other personal protective equipment and engineering controls to protect from blood splatter, blood leakage and potential exposure to blood-borne pathogens.
  2. All glass has the potential for breakage. Examine all glass for potential damage in transit before use and take precautionary measures during handling.
  3. Handle all biologic samples and blood collection “sharps” (lancets, needles, luer adapters, and blood collection sets) according to the policies and procedures of your facility. Obtain appropriate medical attention in the event of any exposure to biologic samples (for example, through a puncture injury) since they may transmit viral hepatitis, HIV (AIDS), or other infectious diseases. Utilize any built-in used needle protector, if the blood collection device provides one. Estar Technologies Ltd. does not recommend reshielding used needles.
  4. Discard all blood collection “sharps” in biohazard containers approved for their disposal.
  5. Transferring a sample from a syringe to a tube is not recommended. Additional manipulation of sharps increases the potential for needlestick injury, in addition, depressing syringe plunger during transfer can create a positive pressure, forcefully displacing the stopper and sample and causing a potential blood exposure. Using a syringe for blood transfer may also cause over or under­filling of tubes, resulting in an incorrect blood-to-additive ratio and potentially incorrect analytic results. Tubes with draw volume smaller than the apparent indicated dimensions may not be filled to their stated volume when filled from a syringe. The laboratory should be consulted regarding the use of these samples.
  6. Underfilling of tubes will result in an incorrect blood-to-additive ratio and may lead to incorrect analytic results or poor product performance.


  1. Damage to blood vessels, hematoma, infection and/or irritation.
  2. Temporary or permanent nerve damage that may result in pain or numbness.
  3. As with any injection-based treatment, infection is a slight possibility.

Want to become a distributor?

Learn More

For USA & Canada visitors: EclipseMedGlobal.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?

Yes, please proceed


Visit the Eclipse USA Site